Financial Year |
March 31 2023 |
Monetary Funds |
675,012,755.91 |
Held-for-trading Financial Assets |
3,000,000.00 |
Notes Receivable |
94,392,198.66 |
Accounts Receivable |
660,461,698.13 |
Advances to Suppliers |
22,936,374.63 |
Other Receivables |
27,608,957.15 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
572,831,294.10 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
70,641,024.32 |
Total Current Assets |
2,336,050,384.06 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
1,494,423.76 |
Investment Properties |
105,830,246.58 |
Fixed Assetes |
241,263,388.91 |
Under-construction Projects |
4,654,310.26 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
49,714,317.70 |
R&D expenses |
-- |
Goodwill |
22,195.80 |
Long-Term Deferred and Prepaid Expenses |
1,670,649.06 |
Deferred Income Tax Assets |
36,272,954.24 |
Other Non-Current Assets |
25,427,537.43 |
Sub-Total of Non-Current Assets |
519,160,824.71 |
Total Assets |
2,855,211,208.77 |
Short-Term Loans |
119,954,929.97 |
Trading Financial liabilities |
-- |
Notes Payable |
18,078,503.66 |
Accounts Payable |
261,184,039.12 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
67,283,777.93 |
Taxes Payable |
19,451,392.89 |
Interest Payable |
4,640,940.03 |
Dividend Payable |
-- |
Other payables |
77,271,750.43 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
137,593,892.96 |
Other Current Liabilities |
8,461,853.63 |
Sub-Total of Current Liabilities |
1,096,722,729.00 |
Long-term Loans |
29,000,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
9,097,180.09 |
Deferred Income Tax Liabilities |
258,709.69 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
145,268,896.70 |
Total Liabilities |
1,241,991,625.70 |
Paid-In Capital(Or Share Stock) |
305,105,697.00 |
Capital Surplus |
391,818,838.25 |
Surplus Reserve |
60,199,584.46 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
784,051,641.31 |
Minority Stockholder's Interest |
37,561,500.29 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,575,658,082.78 |
Owner's Equity(Stockholder's Equity) |
1,613,219,583.07 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,855,211,208.77 |